-
DE
Insulin receptor therapy refers to treatments that target the insulin receptor to improve or restore its function, helping to manage metabolic conditions such as type 2 diabetes.
Insulin receptor therapy refers to treatments that target the insulin receptor to improve or restore its function, helping to manage metabolic conditions such as type 2 diabetes.
Insulin receptor therapy encompasses therapeutic strategies that directly target the insulin receptor in order to modulate, enhance, or restore its function. The insulin receptor is a protein located on the surface of body cells that binds the hormone insulin, triggering the uptake of glucose (sugar) into cells. When this receptor is impaired or cells no longer respond adequately to insulin, the result is insulin resistance -- a hallmark of type 2 diabetes mellitus.
The insulin receptor belongs to the class of tyrosine kinase receptors. When insulin binds to the receptor, it initiates an intracellular signaling cascade that causes glucose transporters (GLUT4) to migrate to the cell surface, enabling glucose uptake. Disruptions in this signaling pathway can lead to elevated blood glucose levels, obesity, and various metabolic disorders.
Several drug classes act directly or indirectly on the insulin receptor:
For rare genetic insulin receptor defects, gene therapy strategies are being explored. These approaches aim to correct or replace defective sequences in the insulin receptor gene and are currently in preclinical or early clinical trial stages.
Non-pharmacological interventions are also a key component of insulin receptor therapy:
Clinical research is increasingly developing bispecific antibodies and insulin mimetics that activate the insulin receptor more selectively than conventional insulin preparations. The goal is to minimize side effects such as hypoglycemia and weight gain.
Diagnosing insulin receptor dysfunction typically involves the following assessments:
Insulin receptor therapy is gaining increasing importance as insulin resistance and type 2 diabetes continue to rise globally. Beyond treating type 2 diabetes, targeted modulation of the insulin receptor also opens new avenues for managing metabolic syndrome, polycystic ovary syndrome (PCOS), and rare genetic conditions. Research in this field is highly active and holds great promise for future treatment options.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.